APA (7th ed.) Citation

Nauck, M. A., Wollschläger, D., Werner, J., Holst, J. J., Ørskov, C., Creutzfeldt, W., & Willms, B. (1996). Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7–36 amide]) in patients with NIDDM. Springer.

Chicago Style (17th ed.) Citation

Nauck, M. A., D. Wollschläger, J. Werner, J. J. Holst, C. Ørskov, W. Creutzfeldt, and B. Willms. Effects of Subcutaneous Glucagon-like Peptide 1 (GLP-1 [7–36 Amide]) in Patients with NIDDM. Springer, 1996.

MLA (9th ed.) Citation

Nauck, M. A., et al. Effects of Subcutaneous Glucagon-like Peptide 1 (GLP-1 [7–36 Amide]) in Patients with NIDDM. Springer, 1996.